REGN vs STRA · P/E 14, rev $14.34B vs P/E 13, rev $1.22B
Regeneron Pharmaceuticals Inc (REGN) versus Strategic Education Inc (STRA) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Strategic Education Inc (STRA) is a education & training services company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported STRA revenue for 2024-12-31 was $1.22B. Net income was $112.7M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. STRA currently screens at market cap $1.71B and trailing P/E 13.3.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. STRA currently screens at market cap $1.71B and trailing P/E 13.3.
Not investment advice. Open the REGN and STRA stock pages for the full models.
Not investment advice.